Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Beneficial Growing Conditions in West Africa Weigh on Cocoa Prices - 2At least 11 killed in South Africa mass shooting
- 3How HIV/AIDS got its name − the words Americans used for the crisis were steeped in science, stigma and religious language
- 4My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs
- 5Down to earth Manual for A Modest Hyundai Ioniq Electric for Seniors
- Step by step instructions to Shield Your Wellbeing Around 5G Pinnacles\
- Congo declares its latest Ebola outbreak over, after 43 deaths
- 6 Nations for Setting up camp
- Find the Standards of Viable Nurturing: Supporting Blissful and Strong Kids
- Indoor Drinking Fountains: Famous Home Advancements during the Pandemic
- How AI fixed the James Webb Space Telescope's blurry vision
- Experts who once backed 'shaken baby' science now fight to free imprisoned caregivers
- Israel kidnaps PIJ terrorist in covert op. in Hamas-controlled Gaza in pursuit of Ran Gvili
- Cannabis reclassification could 'open the floodgates' for research, scientists say
